PMID 32644742
Endothelial cell studies report increased proliferation, migration, and tube formation in culture systems that measure angiogenic signaling behavior
Good product, will reorder
Clinical, diagnostic, therapeutic, recreational, cosmetic, veterinary, and personal uses are prohibited
Combine an unapproved compound, an evolving regulatory picture, and a product bought as a "research chemical" of unverified identity, purity, and sterility, and the gap between online enthusiasm and responsible practice becomes obvious
Common Side Effects of Tirzepatide and Semaglutide The most frequently reported side effects include: Nausea (particularly during dose increases) Diarrhea or constipation Vomiting Abdominal discomfort Decreased appetite (expected effect) Most side effects occur during dose escalation and typically improve within 4-8 weeks as your body adjusts to the medication